Needles are soon to be a thing of the past. Eli Lilly’s new GLP-1 drug, Foundayo, received approval from the Food and Drug ...

A new GLP-1 weight loss drug called survodutide has shown promising results in a phase 3 clinical trial. The drug, which ...

P004 represents a first-in-class application of GLP-1 receptor agonism in the intra-articular space, specifically targeting patients with knee osteoarthritis and synovitis who have failed multiple ...

Novo Nordisk has said its triple-action obesity therapy UBT251 – licensed from United Biotechnology – achieved close to 20% weight loss at 24 weeks in a mid-stage trial. The results in a Chinese ...

Prescribing smaller GLP-1 receptor agonist doses could help users tolerate the drugs and lead to a more patient-centered ...

Discover the top 16 websites for buying GLP-1 weight loss medications online. Our expert-reviewed guide helps you find safe ...